XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit Plans (Tables)
9 Months Ended
Oct. 01, 2017
Employee Benefits and Share-based Compensation [Abstract]  
Schedule Of Stock Option Activity

Option Activity

Stock option activity during the nine months ended October 1, 2017 was as follows:
 
Number of shares
 
Weighted Average Exercise Price Per Share
 
(In thousands)
 
(In dollars)
Outstanding as of December 31, 2016
1,884

 
$
31.14

Granted
328

 
42.70

Exercised
(230
)
 
27.83

Cancelled

 

Expired
(1
)
 
31.70

Outstanding as of October 1, 2017
1,981

 
$
33.44

Schedule Of RSU Activity

RSU Activity

RSU activity during the nine months ended October 1, 2017 was as follows:
 
Number of shares
 
Weighted Average Grant Date Fair Value Per Share
 
(In thousands)
 
(In dollars)
Outstanding as of December 31, 2016
996

 
$
36.22

Granted
553

 
49.50

Vested
(382
)
 
35.13

Cancelled
(54
)
 
43.87

Outstanding as of October 1, 2017
1,113

 
$
42.83


Schedule Of Valuation And Expense Information
The table below sets forth the weighted average assumptions used to estimate the fair value of option grants and purchase rights granted under the ESPP during the three and nine months ended October 1, 2017 and October 2, 2016.
 
Three Months Ended
 
Nine Months Ended
 
Stock Options
 
ESPP
 
Stock Options
 
ESPP
 
October 1,
2017
 
October 2,
2016
 
October 1,
2017
 
October 2,
2016
 
October 1,
2017
 
October 2,
2016
 
October 1,
2017
 
October 2,
2016
Expected life (in years)
NA
 
NA
 
0.5

 
0.5

 
4.4

 
4.4

 
0.5

 
0.5

Risk-free interest rate
NA
 
NA
 
1.12
%
 
0.45
%
 
1.65
%
 
1.28
%
 
0.93
%
 
0.43
%
Expected volatility
NA
 
NA
 
31.3
%
 
28.6
%
 
31.6
%
 
35.4
%
 
29.7
%
 
38.3
%
Dividend yield
NA
 
NA
 

 

 

 

 

 

Schedule Of Total Stock-Based Compensation Expense Resulting From Stock Options, Restricted Stock Awards, And The Employee Stock Purchase Plan

The following table sets forth the stock-based compensation expense resulting from stock options, RSUs and the ESPP included in the Company’s unaudited condensed consolidated statements of operations:
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2017
 
October 2,
2016
 
October 1,
2017
 
October 2,
2016
 
(In thousands)
Cost of revenue
$
499

 
$
426

 
$
1,477

 
$
1,316

Research and development
1,056

 
1,087

 
3,748

 
3,071

Sales and marketing
1,654

 
1,300

 
4,339

 
3,835

General and administrative
2,374

 
2,057

 
6,848

 
6,078

Total stock-based compensation
$
5,583

 
$
4,870

 
$
16,412

 
$
14,300